Clinical trials: Intrauterine Growth Retardation

Growth Disorders, Intrauterine Growth Retardation

Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation

• Completed
• Age: 3 to 12 years
• Phase 3
• Injection or infusion
• Results posted

To evaluate the effect of continuous and intermittent administration of Genotonorm on stature in short prepubertal children with intra-uterine growth retardation

Trial name

NCT01073605

Testing

Genotonorm

Where

31 sites in France

Volunteers

208 people

Sponsor

Pfizer